Kerem Ben‐Meir

526 total citations
8 papers, 155 citations indexed

About

Kerem Ben‐Meir is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Kerem Ben‐Meir has authored 8 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Kerem Ben‐Meir's work include Immune cells in cancer (5 papers), Immune Response and Inflammation (3 papers) and Inflammation biomarkers and pathways (1 paper). Kerem Ben‐Meir is often cited by papers focused on Immune cells in cancer (5 papers), Immune Response and Inflammation (3 papers) and Inflammation biomarkers and pathways (1 paper). Kerem Ben‐Meir collaborates with scholars based in Israel, Germany and Myanmar. Kerem Ben‐Meir's co-authors include Michal Baniyash, Shivam Priya, Gabriel Mizraji, Sonja Loges, Avi Maimon, Michael Berger, Tal Burstyn‐Cohen, Yaron Meirow, Ivan Mikula and Jeroen Krijgsveld and has published in prestigious journals such as Journal of Clinical Investigation, Current Opinion in Immunology and Frontiers in Oncology.

In The Last Decade

Kerem Ben‐Meir

8 papers receiving 146 citations

Peers

Kerem Ben‐Meir

IMMUN

MB

ONCOL

CR

PRM

Shuqiang Li United States

Yichao Hua China

Diana Shinko Australia

Anika Habener Germany

Phoebe M. Kirkwood United Kingdom

Shai Dulberg Israel

Sheri A. C. McDowell Canada

Maria Chiara Gelmi Netherlands

Magar Ghazarian Canada

Sandra S. Ring Switzerland

Shuqiang Li United States

Kerem Ben‐Meir

55 ×0.6

IMMUN

61 ×1.2

MB

26 ×0.7

ONCOL

13 ×0.8

CR

6 ×0.5

PRM

Citations per year, relative to Kerem Ben‐Meir Kerem Ben‐Meir (= 1×) peers Shuqiang Li

Countries citing papers authored by Kerem Ben‐Meir

Since Specialization

Citations

This map shows the geographic impact of Kerem Ben‐Meir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerem Ben‐Meir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerem Ben‐Meir more than expected).

Fields of papers citing papers by Kerem Ben‐Meir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerem Ben‐Meir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerem Ben‐Meir. The network helps show where Kerem Ben‐Meir may publish in the future.

Co-authorship network of co-authors of Kerem Ben‐Meir

This figure shows the co-authorship network connecting the top 25 collaborators of Kerem Ben‐Meir. A scholar is included among the top collaborators of Kerem Ben‐Meir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerem Ben‐Meir. Kerem Ben‐Meir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Uzan-Yulzari, Atara, Sondra Turjeman, Kerem Ben‐Meir, et al.. (2024). The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development. Cancer Research Communications. 4(4). 1063–1081. 6 indexed citations

2.

Ben‐Meir, Kerem, Adi Haber, Ignace Vergote, et al.. (2024). Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance. Frontiers in Oncology. 14. 1402851–1402851. 3 indexed citations

3.

Meirow, Yaron, Daniele Colombo, Kerem Ben‐Meir, et al.. (2022). Specific inflammatory osteoclast precursors induced during chronic inflammation give rise to highly active osteoclasts associated with inflammatory bone loss. Bone Research. 10(1). 36–36. 29 indexed citations

4.

Ben‐Meir, Kerem, et al.. (2022). An In Vivo Mouse Model for Chronic Inflammation–Induced Immune Suppression: A “Factory” for Myeloid‐Derived Suppressor Cells (MDSCs). Current Protocols. 2(10). e558–e558. 3 indexed citations

5.

Mikula, Ivan, et al.. (2022). Functional Assays Evaluating Immunosuppression Mediated by Myeloid‐Derived Suppressor Cells. Current Protocols. 2(10). e557–e557. 4 indexed citations

6.

Mikula, Ivan, et al.. (2022). Phenotypic Characterization and Isolation of Myeloid‐Derived Suppressor Cells. Current Protocols. 2(10). e561–e561. 3 indexed citations

7.

Maimon, Avi, Kerem Ben‐Meir, Shivam Priya, et al.. (2021). Myeloid cell–derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10. Journal of Clinical Investigation. 131(10). 54 indexed citations

8.

Ben‐Meir, Kerem, et al.. (2018). Plasticity and biological diversity of myeloid derived suppressor cells. Current Opinion in Immunology. 51. 154–161. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact